Literature DB >> 21959788

Therapeutic drug monitoring in Italian psychiatry.

A Conca1, E Schmidt, M Pastore, C Hiemke, D Duffy, G Giupponi.   

Abstract

INTRODUCTION: Therapeutic drug monitoring (TDM) aims to optimize pharmacotherapy treatment. Knowledge, availability and use of TDM for psychiatric patients, however, differ between countries. In this survey we analysed the practice in Italy of TDM for psychoactive drugs.
METHODS: A semi-structured questionnaire was sent out to 211 mental health centres (centro di salute mentale) and 10 university hospitals from each region in Italy.
RESULTS: Feedback was obtained from 44 centres. Information collected by the questionnaires indicated that in Italian psychiatry TDM is used for lithium, valproic acid and carbamazepine. With regard to clozapine, TDM was regarded as the blood cell counting which is obligatory when prescribing this drug. TDM was not employed for antidepressant or antipsychotic drug prescribing. Moreover, it appeared that only a few laboratories in Italy offer TDM services for psychiatric patients. Nevertheless, interest was expressed about receiving further information about TDM in psychiatry and participating in training programmes. DISCUSSION: This nationwide survey revealed that in Italy, TDM of psychoactive drugs is restricted to only a few drugs. In response to interest expressed, mental health workers should be educated about TDM and more laboratories should be encouraged to establish TDM services for psychotropic drugs. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959788     DOI: 10.1055/s-0031-1286281

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  6 in total

1.  Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.

Authors:  Suzanne Law; Peter M Haddad; Imran B Chaudhry; Nusrat Husain; Richard J Drake; Robert J Flanagan; Anthony S David; Maxine X Patel
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

2.  Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms.

Authors:  Robert McCutcheon; Katherine Beck; Michael A P Bloomfield; Tiago R Marques; Maria Rogdaki; Oliver D Howes
Journal:  J Psychopharmacol       Date:  2015-03-18       Impact factor: 4.153

3.  Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis.

Authors:  Susanna M Wallerstedt; Jonatan D Lindh
Journal:  Ther Drug Monit       Date:  2015-08       Impact factor: 3.681

4.  Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database.

Authors:  Nobuhiro Ooba; Daisuke Tsutsumi; Naoko Kobayashi; Shinji Hidaka; Hiroyuki Hayashi; Taku Obara; Michihiro Satoh; Kiyoshi Kubota; Noriyasu Fukuoka
Journal:  Ther Drug Monit       Date:  2018-04       Impact factor: 3.681

5.  Patterns of Prescription of Psychotropic Medications and Their Adherence among Patients with Schizophrenia in Two Psychiatric Hospitals in Accra, Ghana: A Cross-Sectional Survey.

Authors:  Sharon Ashong; Irene A Kretchy; Barima Afrane; Ama de-Graft Aikins
Journal:  Psychiatry J       Date:  2018-01-01

6.  Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.

Authors:  R McCutcheon; K Beck; E D'Ambrosio; J Donocik; C Gobjila; S Jauhar; S Kaar; T Pillinger; T Reis Marques; M Rogdaki; O D Howes
Journal:  Acta Psychiatr Scand       Date:  2017-10-26       Impact factor: 6.392

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.